Gland Pharma Limited — Important, 04-06-2025: General Updates
04-06-2025 | 06:57 pm
04-06-2025 | 06:57 pm
Gland Pharma’s subsidiary Cenexi received 11 observations in a French GMP inspection. A corrective action plan, approved by regulators, is underway with expected completion in 3-12 months. Manufacturing operations will continue without interruption. The company is actively working with authorities and will provide updates on progress.
No comments yet. Be the first to comment!
